- Telehealth Visits
Reva Frankel, MD
She | Her | HersMedical Genetics and Genomics- Telehealth Visits
Reva Frankel, MD
She | Her | HersMedical Genetics and Genomics- Telehealth Visits
On this page
About me
Dr. Reva Frankel is a medical geneticist who cares for patients with suspected or confirmed hereditary disorders. She sees children with multiple birth defects, hearing loss, developmental delays, intellectual disabilities and autism spectrum disorder, as well as those with family histories of a genetic condition. She strives to help patients and families navigate the complexities of genetic testing and rare diseases.
Frankel attended the Medical School for International Health at Ben-Gurion University of the Negev in Israel. She completed a residency in pediatrics at MedStar Georgetown University Hospital, where she served as chief resident. She also completed a residency in medical genetics and genomics at Stanford University.
Frankel is a fellow of the American Academy of Pediatrics and American College of Medical Genetics and Genomics.
Education
Board Certification
- Clinical Genetics and Genomics, American Board of Medical Genetics and Genomics
- Pediatrics, American Board of Pediatrics
Residency
- Medical Genetics & Genomics, Stanford University Medical Center-GME
- Pediatrics, Georgetown University Hospital GME - Medstar
School
- MD, Ben Gurion University of the Negev Faculty of Health Sciences
Academic Title
- Health Sciences Clinical Professor
Care Keywords
Services
- Medical Genetics and Genomics
Locations
Provider Research Listing
Browse clinical trials and publications by this provider
Please check with your health insurance plan regarding coverage for this type of care. Not all providers at UCSF Health are covered by every insurance plan.
For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here.
The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.